Ascendis Pharma A/S - ASND
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2026
· Q2 2026
Value (USD)
Total reported value ($000)
$144.2M
QoQ value delta ($000)
-$104K
(-0.07%)
Implied price effect (QoQ)
-0.07%
Shares
Total shares
541,373
QoQ shares delta
-14
(-0.0%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (ASND)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2026)
Top 25 only
Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 60,053 | 225,155 | 1.31% |
| Neuberger Berman Group LLC | 38,062 | 142,705 | 0.03% |
| ODDO BHF ASSET MANAGEMENT SAS | 34,315 | 128,657 | 1.59% |
| Quadrature Capital Ltd | 10,894 | 40,845 | 0.09% |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | 592 | 2,600 | 0.01% |
| DEARBORN PARTNERS LLC | 297 | 1,300 | 0.02% |
| E Fund Management (Hong Kong) Co., Ltd. | 22 | 84 | 0.01% |
| Ninepoint Partners LP | 6 | 26 | 0.0% |
| HUNTINGTON NATIONAL BANK | 0 | 1 | 0.0% |